Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Escherichia coli | peptide deformylase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | tar DNA-binding protein | 0.0066 | 0.0794 | 0.0794 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0066 | 0.0794 | 0.1199 |
Onchocerca volvulus | 0.0233 | 0.7808 | 1 | |
Trypanosoma brucei | Peptide deformylase 2 | 0.0106 | 0.2491 | 0.5 |
Echinococcus multilocularis | tar DNA binding protein | 0.0066 | 0.0794 | 0.1371 |
Brugia malayi | RNA binding protein | 0.0066 | 0.0794 | 0.1199 |
Brugia malayi | Pre-SET motif family protein | 0.0205 | 0.6622 | 1 |
Mycobacterium leprae | PROBABLE POLYPEPTIDE DEFORMYLASE DEF (PDF) (FORMYLMETHIONINE DEFORMYLASE) | 0.0279 | 0.9718 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0066 | 0.0794 | 0.0794 |
Schistosoma mansoni | tar DNA-binding protein | 0.0066 | 0.0794 | 0.0794 |
Trypanosoma cruzi | polypeptide deformylase-like protein, putative | 0.0106 | 0.2491 | 0.5 |
Treponema pallidum | polypeptide deformylase (def) | 0.0279 | 0.9718 | 0.5 |
Echinococcus multilocularis | endonuclease exonuclease phosphatase | 0.0185 | 0.579 | 1 |
Echinococcus granulosus | suppression of tumorigenicity 18 protein | 0.0053 | 0.0273 | 0.0471 |
Chlamydia trachomatis | peptide deformylase | 0.0279 | 0.9718 | 0.5 |
Brugia malayi | C2-HC type zinc finger protein C.e-MyT1 | 0.0053 | 0.0273 | 0.0412 |
Echinococcus granulosus | tar DNA binding protein | 0.0066 | 0.0794 | 0.1371 |
Trypanosoma cruzi | Peptide deformylase 2, putative | 0.0106 | 0.2491 | 0.5 |
Loa Loa (eye worm) | MBCTL1 | 0.0053 | 0.0273 | 0.0412 |
Trypanosoma cruzi | polypeptide deformylase-like protein, putative | 0.0106 | 0.2491 | 0.5 |
Plasmodium falciparum | peptide deformylase | 0.0279 | 0.9718 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.0273 | 0.0412 |
Schistosoma mansoni | tar DNA-binding protein | 0.0066 | 0.0794 | 0.0794 |
Schistosoma mansoni | myelin transcription factor 1 myt1 | 0.0053 | 0.0273 | 0.0273 |
Trypanosoma cruzi | Peptide deformylase 2, putative | 0.0106 | 0.2491 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | peptide deformylase | 0.0279 | 0.9718 | 0.5 |
Mycobacterium ulcerans | peptide deformylase | 0.0279 | 0.9718 | 0.5 |
Trypanosoma brucei | Polypeptide deformylase 1 | 0.0106 | 0.2491 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0066 | 0.0794 | 0.0794 |
Plasmodium vivax | peptide deformylase, putative | 0.0279 | 0.9718 | 0.5 |
Loa Loa (eye worm) | TAR-binding protein | 0.0066 | 0.0794 | 0.1199 |
Echinococcus granulosus | endonuclease exonuclease phosphatase | 0.0185 | 0.579 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0066 | 0.0794 | 0.1199 |
Mycobacterium tuberculosis | Probable polypeptide deformylase Def (PDF) (formylmethionine deformylase) | 0.0279 | 0.9718 | 0.5 |
Loa Loa (eye worm) | RNA binding protein | 0.0066 | 0.0794 | 0.1199 |
Leishmania major | polypeptide deformylase-like protein, putative | 0.0106 | 0.2491 | 0.5 |
Echinococcus multilocularis | histone acetyltransferase MYST2 | 0.0053 | 0.0273 | 0.0471 |
Brugia malayi | TAR-binding protein | 0.0066 | 0.0794 | 0.1199 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0205 | 0.6622 | 1 |
Toxoplasma gondii | hypothetical protein | 0.0279 | 0.9718 | 0.5 |
Echinococcus multilocularis | suppression of tumorigenicity 18 protein | 0.0053 | 0.0273 | 0.0471 |
Echinococcus granulosus | histone acetyltransferase MYST2 | 0.0053 | 0.0273 | 0.0471 |
Trichomonas vaginalis | set domain proteins, putative | 0.0233 | 0.7808 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 300 nM | Inhibition of Escherichia coli nickel containing peptide deformylase | ChEMBL. | 21621999 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.